id	sid	tid	token	lemma	pos
dpc-2569	1	1	dermatology	dermatology	NOUN
dpc-2569	1	2	:	:	PUNCT
dpc-2569	1	3	practical	practical	ADJ
dpc-2569	1	4	and	and	CCONJ
dpc-2569	1	5	conceptual	conceptual	ADJ
dpc-2569	1	6	research	research	NOUN
dpc-2569	1	7	letter	letter	NOUN
dpc-2569	2	1	|	|	ADV
dpc-2569	2	2	dermatol	dermatol	ADJ
dpc-2569	2	3	pract	pract	NOUN
dpc-2569	2	4	concept	concept	NOUN
dpc-2569	2	5	.	.	PUNCT
dpc-2569	3	1	2023;13(2):e2023071	2023;13(2):e2023071	NUM
dpc-2569	3	2	1	1	NUM
dpc-2569	3	3	acquired	acquire	VERB
dpc-2569	3	4	bilateral	bilateral	ADJ
dpc-2569	3	5	nevoid	nevoid	PROPN
dpc-2569	3	6	telangiectasia	telangiectasia	NOUN
dpc-2569	3	7	induced	induce	VERB
dpc-2569	3	8	 	 	SPACE
dpc-2569	3	9	by	by	ADP
dpc-2569	3	10	tamoxifen	tamoxifen	PROPN
dpc-2569	3	11	irene	irene	PROPN
dpc-2569	3	12	navarro	navarro	PROPN
dpc-2569	3	13	-	-	PUNCT
dpc-2569	3	14	navarro1	navarro1	PROPN
dpc-2569	3	15	,	,	PUNCT
dpc-2569	3	16	alejandro	alejandro	PROPN
dpc-2569	3	17	ortiz	ortiz	PROPN
dpc-2569	3	18	-	-	PUNCT
dpc-2569	3	19	prieto1	prieto1	PROPN
dpc-2569	3	20	,	,	PUNCT
dpc-2569	3	21	gonzalo	gonzalo	PROPN
dpc-2569	3	22	gallo	gallo	PROPN
dpc-2569	3	23	-	-	PUNCT
dpc-2569	3	24	pineda1	pineda1	PROPN
dpc-2569	3	25	,	,	PUNCT
dpc-2569	3	26	myriam	myriam	PROPN
dpc-2569	3	27	viedma	viedma	PROPN
dpc-2569	3	28	-	-	PUNCT
dpc-2569	3	29	martínez1	martínez1	PROPN
dpc-2569	3	30	,	,	PUNCT
dpc-2569	3	31	david	david	PROPN
dpc-2569	3	32	jiménez	jiménez	PROPN
dpc-2569	3	33	-	-	PUNCT
dpc-2569	3	34	gallo1	gallo1	PROPN
dpc-2569	3	35	,	,	PUNCT
dpc-2569	3	36	mario	mario	PROPN
dpc-2569	3	37	linares	linares	PROPN
dpc-2569	3	38	-	-	PUNCT
dpc-2569	3	39	barrios1	barrios1	PROPN
dpc-2569	3	40	1	1	NUM
dpc-2569	3	41	unidad	unidad	PROPN
dpc-2569	3	42	de	de	PROPN
dpc-2569	3	43	gestión	gestión	PROPN
dpc-2569	3	44	clínica	clínica	PROPN
dpc-2569	3	45	de	de	PROPN
dpc-2569	3	46	dermatología	dermatología	PROPN
dpc-2569	3	47	médico	médico	PROPN
dpc-2569	3	48	-	-	PUNCT
dpc-2569	3	49	quirúrgica	quirúrgica	PROPN
dpc-2569	3	50	y	y	PROPN
dpc-2569	3	51	venereología	venereología	PROPN
dpc-2569	3	52	,	,	PUNCT
dpc-2569	3	53	hospital	hospital	NOUN
dpc-2569	3	54	universitario	universitario	PROPN
dpc-2569	3	55	puerta	puerta	PROPN
dpc-2569	3	56	del	del	PROPN
dpc-2569	3	57	mar	mar	PROPN
dpc-2569	3	58	,	,	PUNCT
dpc-2569	3	59	cádiz	cádiz	PROPN
dpc-2569	3	60	,	,	PUNCT
dpc-2569	3	61	españa	españa	ADJ
dpc-2569	3	62	key	key	ADJ
dpc-2569	3	63	words	word	NOUN
dpc-2569	3	64	:	:	PUNCT
dpc-2569	3	65	bilateral	bilateral	ADJ
dpc-2569	3	66	nevoid	nevoid	PROPN
dpc-2569	3	67	telangiectasia	telangiectasia	PROPN
dpc-2569	3	68	,	,	PUNCT
dpc-2569	3	69	tamoxifen	tamoxifen	PROPN
dpc-2569	3	70	citation	citation	NOUN
dpc-2569	3	71	:	:	PUNCT
dpc-2569	4	1	navarro	navarro	PROPN
dpc-2569	4	2	-	-	PUNCT
dpc-2569	4	3	navarro	navarro	PROPN
dpc-2569	4	4	i	i	PROPN
dpc-2569	4	5	,	,	PUNCT
dpc-2569	4	6	ortiz	ortiz	PROPN
dpc-2569	4	7	-	-	PUNCT
dpc-2569	4	8	prieto	prieto	PROPN
dpc-2569	4	9	a	a	PRON
dpc-2569	4	10	,	,	PUNCT
dpc-2569	4	11	gallo	gallo	PROPN
dpc-2569	4	12	-	-	PUNCT
dpc-2569	4	13	pineda	pineda	PROPN
dpc-2569	4	14	g	g	PROPN
dpc-2569	4	15	,	,	PUNCT
dpc-2569	4	16	viedma	viedma	NOUN
dpc-2569	4	17	-	-	PUNCT
dpc-2569	4	18	martínez	martínez	PROPN
dpc-2569	4	19	m	m	PROPN
dpc-2569	4	20	,	,	PUNCT
dpc-2569	4	21	jiménez	jiménez	PROPN
dpc-2569	4	22	-	-	PUNCT
dpc-2569	4	23	gallo	gallo	PROPN
dpc-2569	4	24	d	d	PROPN
dpc-2569	4	25	,	,	PUNCT
dpc-2569	4	26	linares	linare	NOUN
dpc-2569	4	27	-	-	PUNCT
dpc-2569	4	28	barrios	barrio	NOUN
dpc-2569	4	29	m.	m.	NOUN
dpc-2569	4	30	acquired	acquire	VERB
dpc-2569	4	31	bilateral	bilateral	ADJ
dpc-2569	4	32	nevoid	nevoid	PROPN
dpc-2569	4	33	telangiectasia	telangiectasia	NOUN
dpc-2569	4	34	induced	induce	VERB
dpc-2569	4	35	by	by	ADP
dpc-2569	4	36	tamoxifen	tamoxifen	PROPN
dpc-2569	4	37	.	.	PUNCT
dpc-2569	5	1	dermatol	dermatol	NOUN
dpc-2569	5	2	pract	pract	PROPN
dpc-2569	5	3	concept	concept	NOUN
dpc-2569	5	4	.	.	PUNCT
dpc-2569	6	1	2023;13(2):e2023071	2023;13(2):e2023071	X
dpc-2569	6	2	.	.	PUNCT
dpc-2569	6	3	doi	doi	PROPN
dpc-2569	6	4	:	:	PUNCT
dpc-2569	6	5	https://doi.org/10.5826/dpc.1302a71	https://doi.org/10.5826/dpc.1302a71	PROPN
dpc-2569	6	6	accepted	accept	VERB
dpc-2569	6	7	:	:	PUNCT
dpc-2569	6	8	july	july	PROPN
dpc-2569	6	9	5	5	NUM
dpc-2569	6	10	,	,	PUNCT
dpc-2569	6	11	2023	2023	NUM
dpc-2569	6	12	;	;	PUNCT
dpc-2569	6	13	published	publish	VERB
dpc-2569	6	14	:	:	PUNCT
dpc-2569	7	1	april	april	PROPN
dpc-2569	7	2	2023	2023	NUM
dpc-2569	7	3	copyright	copyright	NOUN
dpc-2569	7	4	:	:	PUNCT
dpc-2569	7	5	©	©	PROPN
dpc-2569	7	6	2023	2023	NUM
dpc-2569	7	7	navarro	navarro	PROPN
dpc-2569	7	8	-	-	PUNCT
dpc-2569	7	9	navarro	navarro	PROPN
dpc-2569	7	10	et	et	PROPN
dpc-2569	7	11	al	al	PROPN
dpc-2569	7	12	.	.	PUNCT
dpc-2569	8	1	this	this	PRON
dpc-2569	8	2	is	be	AUX
dpc-2569	8	3	an	an	DET
dpc-2569	8	4	open	open	ADJ
dpc-2569	8	5	-	-	PUNCT
dpc-2569	8	6	access	access	NOUN
dpc-2569	8	7	article	article	NOUN
dpc-2569	8	8	distributed	distribute	VERB
dpc-2569	8	9	under	under	ADP
dpc-2569	8	10	the	the	DET
dpc-2569	8	11	terms	term	NOUN
dpc-2569	8	12	of	of	ADP
dpc-2569	8	13	the	the	DET
dpc-2569	8	14	creative	creative	ADJ
dpc-2569	8	15	commons	common	NOUN
dpc-2569	8	16	attribution	attribution	NOUN
dpc-2569	8	17	-	-	PUNCT
dpc-2569	8	18	noncommercial	noncommercial	ADJ
dpc-2569	8	19	license	license	NOUN
dpc-2569	8	20	(	(	PUNCT
dpc-2569	8	21	by	by	ADP
dpc-2569	8	22	-	-	PUNCT
dpc-2569	8	23	nc-4.0	nc-4.0	NOUN
dpc-2569	8	24	)	)	PUNCT
dpc-2569	8	25	,	,	PUNCT
dpc-2569	8	26	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2569	8	27	,	,	PUNCT
dpc-2569	8	28	which	which	PRON
dpc-2569	8	29	permits	permit	VERB
dpc-2569	8	30	unrestricted	unrestricted	ADJ
dpc-2569	8	31	noncommercial	noncommercial	ADJ
dpc-2569	8	32	use	use	NOUN
dpc-2569	8	33	,	,	PUNCT
dpc-2569	8	34	distribution	distribution	NOUN
dpc-2569	8	35	,	,	PUNCT
dpc-2569	8	36	and	and	CCONJ
dpc-2569	8	37	reproduction	reproduction	NOUN
dpc-2569	8	38	in	in	ADP
dpc-2569	8	39	any	any	DET
dpc-2569	8	40	medium	medium	NOUN
dpc-2569	8	41	,	,	PUNCT
dpc-2569	8	42	provided	provide	VERB
dpc-2569	8	43	the	the	DET
dpc-2569	8	44	original	original	ADJ
dpc-2569	8	45	authors	author	NOUN
dpc-2569	8	46	and	and	CCONJ
dpc-2569	8	47	source	source	NOUN
dpc-2569	8	48	are	be	AUX
dpc-2569	8	49	credited	credit	VERB
dpc-2569	8	50	.	.	PUNCT
dpc-2569	9	1	funding	funding	NOUN
dpc-2569	9	2	:	:	PUNCT
dpc-2569	9	3	none	none	NOUN
dpc-2569	9	4	.	.	PUNCT
dpc-2569	10	1	competing	compete	VERB
dpc-2569	10	2	interests	interest	NOUN
dpc-2569	10	3	:	:	PUNCT
dpc-2569	10	4	none	none	NOUN
dpc-2569	10	5	.	.	PUNCT
dpc-2569	11	1	authorship	authorship	NOUN
dpc-2569	11	2	:	:	PUNCT
dpc-2569	11	3	all	all	DET
dpc-2569	11	4	authors	author	NOUN
dpc-2569	11	5	have	have	AUX
dpc-2569	11	6	contributed	contribute	VERB
dpc-2569	11	7	significantly	significantly	ADV
dpc-2569	11	8	to	to	ADP
dpc-2569	11	9	this	this	DET
dpc-2569	11	10	publication	publication	NOUN
dpc-2569	11	11	.	.	PUNCT
dpc-2569	12	1	corresponding	correspond	VERB
dpc-2569	12	2	author	author	NOUN
dpc-2569	12	3	:	:	PUNCT
dpc-2569	12	4	irene	irene	PROPN
dpc-2569	12	5	navarro	navarro	PROPN
dpc-2569	12	6	navarro	navarro	PROPN
dpc-2569	12	7	,	,	PUNCT
dpc-2569	12	8	md	md	PROPN
dpc-2569	12	9	,	,	PUNCT
dpc-2569	12	10	hospital	hospital	NOUN
dpc-2569	12	11	universitario	universitario	PROPN
dpc-2569	12	12	puerta	puerta	PROPN
dpc-2569	12	13	del	del	PROPN
dpc-2569	12	14	mar	mar	PROPN
dpc-2569	12	15	.	.	PROPN
dpc-2569	12	16	unidad	unidad	PROPN
dpc-2569	12	17	de	de	PROPN
dpc-2569	12	18	gestión	gestión	PROPN
dpc-2569	12	19	clínica	clínica	PROPN
dpc-2569	12	20	de	de	X
dpc-2569	12	21	dermatología	dermatología	PROPN
dpc-2569	12	22	,	,	PUNCT
dpc-2569	12	23	2ª	2ª	NUM
dpc-2569	12	24	planta	planta	NOUN
dpc-2569	12	25	.	.	PUNCT
dpc-2569	13	1	avenida	avenida	PROPN
dpc-2569	13	2	ana	ana	PROPN
dpc-2569	13	3	de	de	PROPN
dpc-2569	13	4	viya	viya	PROPN
dpc-2569	13	5	21	21	NUM
dpc-2569	13	6	,	,	PUNCT
dpc-2569	13	7	11009	11009	NUM
dpc-2569	13	8	,	,	PUNCT
dpc-2569	13	9	cádiz	cádiz	PROPN
dpc-2569	13	10	,	,	PUNCT
dpc-2569	13	11	spain	spain	PROPN
dpc-2569	13	12	phone	phone	NOUN
dpc-2569	13	13	:	:	PUNCT
dpc-2569	13	14	+34629924839	+34629924839	NUM
dpc-2569	13	15	e	e	NOUN
dpc-2569	13	16	-	-	NOUN
dpc-2569	13	17	mail	mail	NOUN
dpc-2569	13	18	:	:	PUNCT
dpc-2569	13	19	irenen.navarro@gmail.com	irenen.navarro@gmail.com	X
dpc-2569	13	20	introduction	introduction	NOUN
dpc-2569	13	21	unilateral	unilateral	ADJ
dpc-2569	13	22	nevoid	nevoid	PROPN
dpc-2569	13	23	telangiectasia	telangiectasia	PROPN
dpc-2569	13	24	(	(	PUNCT
dpc-2569	13	25	unt	unt	PROPN
dpc-2569	13	26	)	)	PUNCT
dpc-2569	13	27	is	be	AUX
dpc-2569	13	28	a	a	DET
dpc-2569	13	29	superficial	superficial	ADJ
dpc-2569	13	30	telangiectasia	telangiectasia	NOUN
dpc-2569	13	31	of	of	ADP
dpc-2569	13	32	the	the	DET
dpc-2569	13	33	upper	upper	ADJ
dpc-2569	13	34	body	body	NOUN
dpc-2569	13	35	characterized	characterize	VERB
dpc-2569	13	36	by	by	ADP
dpc-2569	13	37	showing	show	VERB
dpc-2569	13	38	a	a	DET
dpc-2569	13	39	unilateral	unilateral	ADJ
dpc-2569	13	40	dermatomal	dermatomal	ADJ
dpc-2569	13	41	distribution	distribution	NOUN
dpc-2569	13	42	,	,	PUNCT
dpc-2569	13	43	typically	typically	ADV
dpc-2569	13	44	affecting	affect	VERB
dpc-2569	13	45	dermatomes	dermatome	NOUN
dpc-2569	13	46	from	from	ADP
dpc-2569	13	47	c3	c3	PROPN
dpc-2569	13	48	to	to	ADP
dpc-2569	13	49	t3	t3	PROPN
dpc-2569	13	50	[	[	X
dpc-2569	13	51	1	1	NUM
dpc-2569	13	52	]	]	PUNCT
dpc-2569	13	53	.	.	PUNCT
dpc-2569	14	1	although	although	SCONJ
dpc-2569	14	2	the	the	DET
dpc-2569	14	3	exact	exact	ADJ
dpc-2569	14	4	cause	cause	NOUN
dpc-2569	14	5	is	be	AUX
dpc-2569	14	6	unknown	unknown	ADJ
dpc-2569	14	7	,	,	PUNCT
dpc-2569	14	8	the	the	DET
dpc-2569	14	9	association	association	NOUN
dpc-2569	14	10	with	with	ADP
dpc-2569	14	11	hyperestrogenic	hyperestrogenic	ADJ
dpc-2569	14	12	states	state	NOUN
dpc-2569	14	13	has	have	AUX
dpc-2569	14	14	been	be	AUX
dpc-2569	14	15	described	describe	VERB
dpc-2569	14	16	[	[	PUNCT
dpc-2569	14	17	2	2	NUM
dpc-2569	14	18	]	]	PUNCT
dpc-2569	14	19	.	.	PUNCT
dpc-2569	15	1	bilateral	bilateral	ADJ
dpc-2569	15	2	nevoid	nevoid	PROPN
dpc-2569	15	3	telangiectasia	telangiectasia	NOUN
dpc-2569	15	4	(	(	PUNCT
dpc-2569	15	5	bnt	bnt	PROPN
dpc-2569	15	6	)	)	PUNCT
dpc-2569	15	7	is	be	AUX
dpc-2569	15	8	a	a	DET
dpc-2569	15	9	rare	rare	ADJ
dpc-2569	15	10	variant	variant	NOUN
dpc-2569	15	11	of	of	ADP
dpc-2569	15	12	unt	unt	NOUN
dpc-2569	15	13	affecting	affect	VERB
dpc-2569	15	14	both	both	DET
dpc-2569	15	15	sides	side	NOUN
dpc-2569	15	16	of	of	ADP
dpc-2569	15	17	the	the	DET
dpc-2569	15	18	body	body	NOUN
dpc-2569	15	19	.	.	PUNCT
dpc-2569	16	1	we	we	PRON
dpc-2569	16	2	present	present	VERB
dpc-2569	16	3	a	a	DET
dpc-2569	16	4	case	case	NOUN
dpc-2569	16	5	of	of	ADP
dpc-2569	16	6	bnt	bnt	PROPN
dpc-2569	16	7	in	in	ADP
dpc-2569	16	8	relation	relation	NOUN
dpc-2569	16	9	with	with	ADP
dpc-2569	16	10	tamoxifen	tamoxifen	PROPN
dpc-2569	16	11	treatment	treatment	NOUN
dpc-2569	16	12	.	.	PUNCT
dpc-2569	17	1	case	case	NOUN
dpc-2569	17	2	presentation	presentation	NOUN
dpc-2569	17	3	a	a	DET
dpc-2569	17	4	41	41	NUM
dpc-2569	17	5	-	-	PUNCT
dpc-2569	17	6	year	year	NOUN
dpc-2569	17	7	-	-	PUNCT
dpc-2569	17	8	old	old	ADJ
dpc-2569	17	9	female	female	NOUN
dpc-2569	17	10	attended	attend	VERB
dpc-2569	17	11	our	our	PRON
dpc-2569	17	12	dermatology	dermatology	NOUN
dpc-2569	17	13	department	department	NOUN
dpc-2569	17	14	due	due	ADP
dpc-2569	17	15	to	to	ADP
dpc-2569	17	16	the	the	DET
dpc-2569	17	17	appearance	appearance	NOUN
dpc-2569	17	18	of	of	ADP
dpc-2569	17	19	asymptomatic	asymptomatic	ADJ
dpc-2569	17	20	cutaneous	cutaneous	ADJ
dpc-2569	17	21	lesions	lesion	NOUN
dpc-2569	17	22	on	on	ADP
dpc-2569	17	23	the	the	DET
dpc-2569	17	24	upper	upper	ADJ
dpc-2569	17	25	trunk	trunk	NOUN
dpc-2569	17	26	and	and	CCONJ
dpc-2569	17	27	arms	arm	NOUN
dpc-2569	17	28	.	.	PUNCT
dpc-2569	18	1	she	she	PRON
dpc-2569	18	2	had	have	VERB
dpc-2569	18	3	a	a	DET
dpc-2569	18	4	history	history	NOUN
dpc-2569	18	5	of	of	ADP
dpc-2569	18	6	ductal	ductal	ADJ
dpc-2569	18	7	cancer	cancer	NOUN
dpc-2569	18	8	of	of	ADP
dpc-2569	18	9	the	the	DET
dpc-2569	18	10	right	right	ADJ
dpc-2569	18	11	breast	breast	NOUN
dpc-2569	18	12	stage	stage	NOUN
dpc-2569	18	13	ia	ia	PROPN
dpc-2569	18	14	with	with	ADP
dpc-2569	18	15	positivity	positivity	NOUN
dpc-2569	18	16	for	for	ADP
dpc-2569	18	17	estrogen	estrogen	NOUN
dpc-2569	18	18	and	and	CCONJ
dpc-2569	18	19	progesterone	progesterone	NOUN
dpc-2569	18	20	receptors	receptor	NOUN
dpc-2569	18	21	,	,	PUNCT
dpc-2569	18	22	treated	treat	VERB
dpc-2569	18	23	with	with	ADP
dpc-2569	18	24	surgery	surgery	NOUN
dpc-2569	18	25	,	,	PUNCT
dpc-2569	18	26	radiotherapy	radiotherapy	NOUN
dpc-2569	18	27	and	and	CCONJ
dpc-2569	18	28	tamoxifen	tamoxifen	NOUN
dpc-2569	18	29	.	.	PUNCT
dpc-2569	19	1	she	she	PRON
dpc-2569	19	2	did	do	AUX
dpc-2569	19	3	not	not	PART
dpc-2569	19	4	have	have	VERB
dpc-2569	19	5	any	any	DET
dpc-2569	19	6	other	other	ADJ
dpc-2569	19	7	drug	drug	NOUN
dpc-2569	19	8	history	history	NOUN
dpc-2569	19	9	.	.	PUNCT
dpc-2569	20	1	the	the	DET
dpc-2569	20	2	cutaneous	cutaneous	ADJ
dpc-2569	20	3	lesions	lesion	NOUN
dpc-2569	20	4	had	have	AUX
dpc-2569	20	5	appeared	appear	VERB
dpc-2569	20	6	several	several	ADJ
dpc-2569	20	7	weeks	week	NOUN
dpc-2569	20	8	after	after	ADP
dpc-2569	20	9	finishing	finish	VERB
dpc-2569	20	10	radiotherapy	radiotherapy	NOUN
dpc-2569	20	11	and	and	CCONJ
dpc-2569	20	12	starting	start	VERB
dpc-2569	20	13	tamoxifen	tamoxifen	PROPN
dpc-2569	20	14	treatment	treatment	NOUN
dpc-2569	20	15	.	.	PUNCT
dpc-2569	21	1	physical	physical	ADJ
dpc-2569	21	2	examination	examination	NOUN
dpc-2569	21	3	showed	show	VERB
dpc-2569	21	4	symmetric	symmetric	ADJ
dpc-2569	21	5	purpuric	purpuric	ADJ
dpc-2569	21	6	linear	linear	ADJ
dpc-2569	21	7	macules	macule	NOUN
dpc-2569	21	8	on	on	ADP
dpc-2569	21	9	the	the	DET
dpc-2569	21	10	inner	inner	ADJ
dpc-2569	21	11	arms	arm	NOUN
dpc-2569	21	12	,	,	PUNCT
dpc-2569	21	13	chest	chest	NOUN
dpc-2569	21	14	and	and	CCONJ
dpc-2569	21	15	upper	upper	ADJ
dpc-2569	21	16	back	back	NOUN
dpc-2569	21	17	(	(	PUNCT
dpc-2569	21	18	figure	figure	NOUN
dpc-2569	21	19	1	1	NUM
dpc-2569	21	20	)	)	PUNCT
dpc-2569	21	21	.	.	PUNCT
dpc-2569	22	1	the	the	DET
dpc-2569	22	2	macules	macule	NOUN
dpc-2569	22	3	had	have	VERB
dpc-2569	22	4	a	a	DET
dpc-2569	22	5	dermatomal	dermatomal	ADJ
dpc-2569	22	6	distribution	distribution	NOUN
dpc-2569	22	7	following	follow	VERB
dpc-2569	22	8	the	the	DET
dpc-2569	22	9	t1	t1	PROPN
dpc-2569	22	10	dermatome	dermatome	NOUN
dpc-2569	22	11	(	(	PUNCT
dpc-2569	22	12	figure	figure	NOUN
dpc-2569	22	13	2	2	NUM
dpc-2569	22	14	)	)	PUNCT
dpc-2569	22	15	.	.	PUNCT
dpc-2569	23	1	she	she	PRON
dpc-2569	23	2	was	be	AUX
dpc-2569	23	3	interrogated	interrogate	VERB
dpc-2569	23	4	for	for	ADP
dpc-2569	23	5	extracutaneous	extracutaneous	ADJ
dpc-2569	23	6	manifestations	manifestation	NOUN
dpc-2569	23	7	such	such	ADJ
dpc-2569	23	8	as	as	ADP
dpc-2569	23	9	digestive	digestive	ADJ
dpc-2569	23	10	bleeding	bleeding	NOUN
dpc-2569	23	11	or	or	CCONJ
dpc-2569	23	12	epistaxis	epistaxis	ADJ
dpc-2569	23	13	,	,	PUNCT
dpc-2569	23	14	without	without	ADP
dpc-2569	23	15	reporting	report	VERB
dpc-2569	23	16	any	any	DET
dpc-2569	23	17	systemic	systemic	ADJ
dpc-2569	23	18	symptoms	symptom	NOUN
dpc-2569	23	19	.	.	PUNCT
dpc-2569	24	1	a	a	DET
dpc-2569	24	2	skin	skin	NOUN
dpc-2569	24	3	biopsy	biopsy	NOUN
dpc-2569	24	4	showed	show	VERB
dpc-2569	24	5	dilated	dilated	ADJ
dpc-2569	24	6	blood	blood	NOUN
dpc-2569	24	7	vessels	vessel	NOUN
dpc-2569	24	8	in	in	ADP
dpc-2569	24	9	the	the	DET
dpc-2569	24	10	upper	upper	ADJ
dpc-2569	24	11	dermis	dermis	NOUN
dpc-2569	24	12	with	with	ADP
dpc-2569	24	13	mild	mild	ADJ
dpc-2569	24	14	perivascular	perivascular	ADJ
dpc-2569	24	15	inflammation	inflammation	NOUN
dpc-2569	24	16	and	and	CCONJ
dpc-2569	24	17	normal	normal	ADJ
dpc-2569	24	18	number	number	NOUN
dpc-2569	24	19	of	of	ADP
dpc-2569	24	20	mastocyte	mastocyte	NOUN
dpc-2569	24	21	cells	cell	NOUN
dpc-2569	24	22	.	.	PUNCT
dpc-2569	25	1	immunohistochemistry	immunohistochemistry	NOUN
dpc-2569	25	2	showed	show	VERB
dpc-2569	25	3	positivity	positivity	NOUN
dpc-2569	25	4	to	to	ADP
dpc-2569	25	5	estrogen	estrogen	NOUN
dpc-2569	25	6	receptors	receptor	NOUN
dpc-2569	25	7	in	in	ADP
dpc-2569	25	8	fibroblastic	fibroblastic	ADJ
dpc-2569	25	9	cells	cell	NOUN
dpc-2569	25	10	.	.	PUNCT
dpc-2569	26	1	blood	blood	NOUN
dpc-2569	26	2	tests	test	NOUN
dpc-2569	26	3	including	include	VERB
dpc-2569	26	4	biochemistry	biochemistry	NOUN
dpc-2569	26	5	,	,	PUNCT
dpc-2569	26	6	blood	blood	NOUN
dpc-2569	26	7	count	count	NOUN
dpc-2569	26	8	,	,	PUNCT
dpc-2569	26	9	coagulation	coagulation	NOUN
dpc-2569	26	10	study	study	NOUN
dpc-2569	26	11	,	,	PUNCT
dpc-2569	26	12	estrogen	estrogen	NOUN
dpc-2569	26	13	and	and	CCONJ
dpc-2569	26	14	progesterone	progesterone	NOUN
dpc-2569	26	15	levels	level	NOUN
dpc-2569	26	16	and	and	CCONJ
dpc-2569	26	17	viral	viral	ADJ
dpc-2569	26	18	hepatitis	hepatitis	NOUN
dpc-2569	26	19	serology	serology	NOUN
dpc-2569	26	20	were	be	AUX
dpc-2569	26	21	normal	normal	ADJ
dpc-2569	26	22	or	or	CCONJ
dpc-2569	26	23	negative	negative	ADJ
dpc-2569	26	24	.	.	PUNCT
dpc-2569	27	1	stool	stool	NOUN
dpc-2569	27	2	blood	blood	NOUN
dpc-2569	27	3	test	test	NOUN
dpc-2569	27	4	was	be	AUX
dpc-2569	27	5	negative	negative	ADJ
dpc-2569	27	6	.	.	PUNCT
dpc-2569	28	1	she	she	PRON
dpc-2569	28	2	was	be	AUX
dpc-2569	28	3	diagnosed	diagnose	VERB
dpc-2569	28	4	with	with	ADP
dpc-2569	28	5	bnt	bnt	PROPN
dpc-2569	28	6	secondary	secondary	PROPN
dpc-2569	28	7	to	to	ADP
dpc-2569	28	8	tamoxifen	tamoxifen	PROPN
dpc-2569	28	9	.	.	PUNCT
dpc-2569	29	1	conclusions	conclusion	NOUN
dpc-2569	29	2	bnt	bnt	PROPN
dpc-2569	29	3	,	,	PUNCT
dpc-2569	29	4	although	although	SCONJ
dpc-2569	29	5	bilateral	bilateral	ADJ
dpc-2569	29	6	in	in	ADP
dpc-2569	29	7	its	its	PRON
dpc-2569	29	8	presentation	presentation	NOUN
dpc-2569	29	9	,	,	PUNCT
dpc-2569	29	10	is	be	AUX
dpc-2569	29	11	analogous	analogous	ADJ
dpc-2569	29	12	to	to	PART
dpc-2569	29	13	unt	unt	VERB
dpc-2569	29	14	in	in	SCONJ
dpc-2569	29	15	that	that	SCONJ
dpc-2569	29	16	it	it	PRON
dpc-2569	29	17	follows	follow	VERB
dpc-2569	29	18	the	the	DET
dpc-2569	29	19	characteristic	characteristic	ADJ
dpc-2569	29	20	dermatomal	dermatomal	NOUN
dpc-2569	29	21	2	2	NUM
dpc-2569	29	22	research	research	NOUN
dpc-2569	29	23	letter	letter	NOUN
dpc-2569	30	1	|	|	ADV
dpc-2569	30	2	dermatol	dermatol	ADJ
dpc-2569	30	3	pract	pract	NOUN
dpc-2569	30	4	concept	concept	NOUN
dpc-2569	30	5	.	.	PUNCT
dpc-2569	31	1	2023;13(2):e2023071	2023;13(2):e2023071	NUM
dpc-2569	31	2	distribution	distribution	NOUN
dpc-2569	31	3	of	of	ADP
dpc-2569	31	4	the	the	DET
dpc-2569	31	5	telangiectasias	telangiectasia	NOUN
dpc-2569	31	6	.	.	PUNCT
dpc-2569	32	1	however	however	ADV
dpc-2569	32	2	,	,	PUNCT
dpc-2569	32	3	this	this	DET
dpc-2569	32	4	variant	variant	NOUN
dpc-2569	32	5	seems	seem	VERB
dpc-2569	32	6	to	to	PART
dpc-2569	32	7	be	be	AUX
dpc-2569	32	8	less	less	ADV
dpc-2569	32	9	frequent	frequent	ADJ
dpc-2569	32	10	.	.	PUNCT
dpc-2569	33	1	over	over	ADP
dpc-2569	33	2	a	a	DET
dpc-2569	33	3	hundred	hundred	NUM
dpc-2569	33	4	cases	case	NOUN
dpc-2569	33	5	of	of	ADP
dpc-2569	33	6	unt	unt	NOUN
dpc-2569	33	7	have	have	AUX
dpc-2569	33	8	been	be	AUX
dpc-2569	33	9	described	describe	VERB
dpc-2569	33	10	in	in	ADP
dpc-2569	33	11	the	the	DET
dpc-2569	33	12	literature	literature	NOUN
dpc-2569	33	13	,	,	PUNCT
dpc-2569	33	14	and	and	CCONJ
dpc-2569	33	15	only	only	ADV
dpc-2569	33	16	twenty	twenty	NUM
dpc-2569	33	17	-	-	PUNCT
dpc-2569	33	18	four	four	NUM
dpc-2569	33	19	cases	case	NOUN
dpc-2569	33	20	of	of	ADP
dpc-2569	33	21	bnt	bnt	PROPN
dpc-2569	34	1	[	[	X
dpc-2569	34	2	3	3	NUM
dpc-2569	34	3	]	]	PUNCT
dpc-2569	34	4	.	.	PUNCT
dpc-2569	35	1	although	although	SCONJ
dpc-2569	35	2	both	both	DET
dpc-2569	35	3	entities	entity	NOUN
dpc-2569	35	4	are	be	AUX
dpc-2569	35	5	similar	similar	ADJ
dpc-2569	35	6	in	in	ADP
dpc-2569	35	7	their	their	PRON
dpc-2569	35	8	presentation	presentation	NOUN
dpc-2569	35	9	,	,	PUNCT
dpc-2569	35	10	some	some	DET
dpc-2569	35	11	epidemiological	epidemiological	ADJ
dpc-2569	35	12	differences	difference	NOUN
dpc-2569	35	13	have	have	AUX
dpc-2569	35	14	been	be	AUX
dpc-2569	35	15	described	describe	VERB
dpc-2569	35	16	between	between	ADP
dpc-2569	35	17	the	the	DET
dpc-2569	35	18	two	two	NUM
dpc-2569	35	19	variants	variant	NOUN
dpc-2569	35	20	.	.	PUNCT
dpc-2569	36	1	bnt	bnt	PROPN
dpc-2569	36	2	is	be	AUX
dpc-2569	36	3	more	more	ADV
dpc-2569	36	4	frequent	frequent	ADJ
dpc-2569	36	5	in	in	ADP
dpc-2569	36	6	male	male	ADJ
dpc-2569	36	7	patients	patient	NOUN
dpc-2569	36	8	whereas	whereas	SCONJ
dpc-2569	36	9	unt	unt	PROPN
dpc-2569	36	10	occurs	occur	VERB
dpc-2569	36	11	predominantly	predominantly	ADV
dpc-2569	36	12	in	in	ADP
dpc-2569	36	13	women	woman	NOUN
dpc-2569	36	14	.	.	PUNCT
dpc-2569	37	1	patients	patient	NOUN
dpc-2569	37	2	with	with	ADP
dpc-2569	37	3	bnt	bnt	PROPN
dpc-2569	37	4	are	be	AUX
dpc-2569	37	5	usually	usually	ADV
dpc-2569	37	6	older	old	ADJ
dpc-2569	37	7	than	than	ADP
dpc-2569	37	8	those	those	PRON
dpc-2569	37	9	with	with	ADP
dpc-2569	37	10	unt	unt	NOUN
dpc-2569	37	11	,	,	PUNCT
dpc-2569	37	12	with	with	ADP
dpc-2569	37	13	a	a	DET
dpc-2569	37	14	later	later	ADJ
dpc-2569	37	15	onset	onset	NOUN
dpc-2569	37	16	of	of	ADP
dpc-2569	37	17	presentation	presentation	NOUN
dpc-2569	37	18	,	,	PUNCT
dpc-2569	37	19	and	and	CCONJ
dpc-2569	37	20	higher	high	ADJ
dpc-2569	37	21	association	association	NOUN
dpc-2569	37	22	with	with	ADP
dpc-2569	37	23	underlying	underlie	VERB
dpc-2569	37	24	diseases	disease	NOUN
dpc-2569	37	25	such	such	ADJ
dpc-2569	37	26	as	as	ADP
dpc-2569	37	27	liver	liver	NOUN
dpc-2569	37	28	diseases	disease	NOUN
dpc-2569	37	29	,	,	PUNCT
dpc-2569	37	30	diabetes	diabetes	NOUN
dpc-2569	37	31	and	and	CCONJ
dpc-2569	37	32	smoking	smoke	VERB
dpc-2569	37	33	[	[	X
dpc-2569	37	34	4	4	NUM
dpc-2569	37	35	]	]	PUNCT
dpc-2569	37	36	.	.	PUNCT
dpc-2569	38	1	the	the	DET
dpc-2569	38	2	association	association	NOUN
dpc-2569	38	3	of	of	ADP
dpc-2569	38	4	unt	unt	PROPN
dpc-2569	38	5	with	with	ADP
dpc-2569	38	6	hyperestrogenic	hyperestrogenic	ADJ
dpc-2569	38	7	states	state	NOUN
dpc-2569	38	8	has	have	AUX
dpc-2569	38	9	been	be	AUX
dpc-2569	38	10	proposed	propose	VERB
dpc-2569	38	11	,	,	PUNCT
dpc-2569	38	12	owing	owe	VERB
dpc-2569	38	13	to	to	ADP
dpc-2569	38	14	the	the	DET
dpc-2569	38	15	high	high	ADJ
dpc-2569	38	16	prevalence	prevalence	NOUN
dpc-2569	38	17	in	in	ADP
dpc-2569	38	18	patients	patient	NOUN
dpc-2569	38	19	during	during	ADP
dpc-2569	38	20	puberty	puberty	NOUN
dpc-2569	38	21	and	and	CCONJ
dpc-2569	38	22	pregnancy	pregnancy	NOUN
dpc-2569	38	23	[	[	X
dpc-2569	38	24	5	5	NUM
dpc-2569	38	25	]	]	PUNCT
dpc-2569	38	26	.	.	PUNCT
dpc-2569	39	1	tamoxifen	tamoxifen	PROPN
dpc-2569	39	2	is	be	AUX
dpc-2569	39	3	a	a	DET
dpc-2569	39	4	selective	selective	ADJ
dpc-2569	39	5	estrogen	estrogen	NOUN
dpc-2569	39	6	receptor	receptor	NOUN
dpc-2569	39	7	modulator	modulator	NOUN
dpc-2569	39	8	used	use	VERB
dpc-2569	39	9	in	in	ADP
dpc-2569	39	10	breast	breast	NOUN
dpc-2569	39	11	cancer	cancer	NOUN
dpc-2569	39	12	with	with	ADP
dpc-2569	39	13	positivity	positivity	NOUN
dpc-2569	39	14	for	for	ADP
dpc-2569	39	15	hormonal	hormonal	ADJ
dpc-2569	39	16	receptors	receptor	NOUN
dpc-2569	39	17	.	.	PUNCT
dpc-2569	40	1	this	this	DET
dpc-2569	40	2	therapy	therapy	NOUN
dpc-2569	40	3	has	have	VERB
dpc-2569	40	4	an	an	DET
dpc-2569	40	5	antagonist	antagonist	NOUN
dpc-2569	40	6	effect	effect	NOUN
dpc-2569	40	7	on	on	ADP
dpc-2569	40	8	breast	breast	NOUN
dpc-2569	40	9	tissue	tissue	NOUN
dpc-2569	40	10	,	,	PUNCT
dpc-2569	40	11	but	but	CCONJ
dpc-2569	40	12	an	an	DET
dpc-2569	40	13	agonist	agonist	NOUN
dpc-2569	40	14	effect	effect	NOUN
dpc-2569	40	15	on	on	ADP
dpc-2569	40	16	bone	bone	NOUN
dpc-2569	40	17	,	,	PUNCT
dpc-2569	40	18	liver	liver	NOUN
dpc-2569	40	19	,	,	PUNCT
dpc-2569	40	20	skin	skin	NOUN
dpc-2569	40	21	and	and	CCONJ
dpc-2569	40	22	endometrium	endometrium	NOUN
dpc-2569	40	23	.	.	PUNCT
dpc-2569	41	1	association	association	NOUN
dpc-2569	41	2	between	between	ADP
dpc-2569	41	3	unt	unt	PROPN
dpc-2569	41	4	and	and	CCONJ
dpc-2569	41	5	other	other	ADJ
dpc-2569	41	6	drugs	drug	NOUN
dpc-2569	41	7	,	,	PUNCT
dpc-2569	41	8	such	such	ADJ
dpc-2569	41	9	as	as	ADP
dpc-2569	41	10	chemotherapy	chemotherapy	NOUN
dpc-2569	41	11	agents	agent	NOUN
dpc-2569	41	12	,	,	PUNCT
dpc-2569	41	13	has	have	AUX
dpc-2569	41	14	also	also	ADV
dpc-2569	41	15	been	be	AUX
dpc-2569	41	16	proposed	propose	VERB
dpc-2569	41	17	[	[	X
dpc-2569	41	18	6	6	NUM
dpc-2569	41	19	]	]	PUNCT
dpc-2569	41	20	.	.	PUNCT
dpc-2569	42	1	we	we	PRON
dpc-2569	42	2	hypothesize	hypothesize	VERB
dpc-2569	42	3	that	that	SCONJ
dpc-2569	42	4	tamoxifen	tamoxifen	PROPN
dpc-2569	42	5	led	lead	VERB
dpc-2569	42	6	to	to	ADP
dpc-2569	42	7	an	an	DET
dpc-2569	42	8	increase	increase	NOUN
dpc-2569	42	9	of	of	ADP
dpc-2569	42	10	estrogen	estrogen	NOUN
dpc-2569	42	11	receptors	receptor	NOUN
dpc-2569	42	12	on	on	ADP
dpc-2569	42	13	the	the	DET
dpc-2569	42	14	dermatomal	dermatomal	ADJ
dpc-2569	42	15	skin	skin	NOUN
dpc-2569	42	16	of	of	ADP
dpc-2569	42	17	our	our	PRON
dpc-2569	42	18	patient	patient	NOUN
dpc-2569	42	19	,	,	PUNCT
dpc-2569	42	20	which	which	PRON
dpc-2569	42	21	may	may	AUX
dpc-2569	42	22	have	have	AUX
dpc-2569	42	23	been	be	AUX
dpc-2569	42	24	the	the	DET
dpc-2569	42	25	cause	cause	NOUN
dpc-2569	42	26	for	for	ADP
dpc-2569	42	27	the	the	DET
dpc-2569	42	28	presentation	presentation	NOUN
dpc-2569	42	29	of	of	ADP
dpc-2569	42	30	bnt	bnt	PROPN
dpc-2569	42	31	in	in	ADP
dpc-2569	42	32	this	this	DET
dpc-2569	42	33	case	case	NOUN
dpc-2569	42	34	.	.	PUNCT
dpc-2569	43	1	this	this	PRON
dpc-2569	43	2	is	be	AUX
dpc-2569	43	3	the	the	DET
dpc-2569	43	4	first	first	ADJ
dpc-2569	43	5	case	case	NOUN
dpc-2569	43	6	reported	report	VERB
dpc-2569	43	7	,	,	PUNCT
dpc-2569	43	8	to	to	ADP
dpc-2569	43	9	our	our	PRON
dpc-2569	43	10	knowledge	knowledge	NOUN
dpc-2569	43	11	,	,	PUNCT
dpc-2569	43	12	of	of	ADP
dpc-2569	43	13	nevoid	nevoid	PROPN
dpc-2569	43	14	telangiectasia	telangiectasia	PROPN
dpc-2569	43	15	(	(	PUNCT
dpc-2569	43	16	unt	unt	NOUN
dpc-2569	43	17	or	or	CCONJ
dpc-2569	43	18	bnt	bnt	PROPN
dpc-2569	43	19	)	)	PUNCT
dpc-2569	43	20	in	in	ADP
dpc-2569	43	21	relation	relation	NOUN
dpc-2569	43	22	with	with	ADP
dpc-2569	43	23	tamoxifen	tamoxifen	NOUN
dpc-2569	43	24	.	.	PUNCT
dpc-2569	44	1	this	this	PRON
dpc-2569	44	2	contributes	contribute	VERB
dpc-2569	44	3	to	to	ADP
dpc-2569	44	4	the	the	DET
dpc-2569	44	5	hypothesis	hypothesis	NOUN
dpc-2569	44	6	that	that	PRON
dpc-2569	44	7	hyperestrogenic	hyperestrogenic	ADJ
dpc-2569	44	8	states	state	NOUN
dpc-2569	44	9	may	may	AUX
dpc-2569	44	10	be	be	AUX
dpc-2569	44	11	important	important	ADJ
dpc-2569	44	12	not	not	PART
dpc-2569	44	13	only	only	ADV
dpc-2569	44	14	for	for	ADP
dpc-2569	44	15	the	the	DET
dpc-2569	44	16	pathogenesis	pathogenesis	NOUN
dpc-2569	44	17	of	of	ADP
dpc-2569	44	18	unt	unt	NOUN
dpc-2569	44	19	but	but	CCONJ
dpc-2569	44	20	also	also	ADV
dpc-2569	44	21	for	for	ADP
dpc-2569	44	22	bnt	bnt	PROPN
dpc-2569	44	23	.	.	PUNCT
dpc-2569	45	1	however	however	ADV
dpc-2569	45	2	,	,	PUNCT
dpc-2569	45	3	more	more	ADJ
dpc-2569	45	4	studies	study	NOUN
dpc-2569	45	5	directed	direct	VERB
dpc-2569	45	6	to	to	PART
dpc-2569	45	7	explain	explain	VERB
dpc-2569	45	8	the	the	DET
dpc-2569	45	9	underlying	underlie	VERB
dpc-2569	45	10	mechanisms	mechanism	NOUN
dpc-2569	45	11	causing	cause	VERB
dpc-2569	45	12	unt	unt	NOUN
dpc-2569	45	13	and	and	CCONJ
dpc-2569	45	14	bnt	bnt	PROPN
dpc-2569	45	15	are	be	AUX
dpc-2569	45	16	needed	need	VERB
dpc-2569	45	17	to	to	PART
dpc-2569	45	18	validate	validate	VERB
dpc-2569	45	19	our	our	PRON
dpc-2569	45	20	observations	observation	NOUN
dpc-2569	45	21	.	.	PUNCT
dpc-2569	46	1	references	reference	NOUN
dpc-2569	46	2	1	1	NUM
dpc-2569	46	3	.	.	PUNCT
dpc-2569	47	1	duong	duong	PROPN
dpc-2569	47	2	mh	mh	PROPN
dpc-2569	47	3	,	,	PUNCT
dpc-2569	47	4	raymond	raymond	PROPN
dpc-2569	47	5	cp	cp	PROPN
dpc-2569	47	6	.	.	PROPN
dpc-2569	47	7	unilateral	unilateral	ADJ
dpc-2569	47	8	dermatomal	dermatomal	ADJ
dpc-2569	47	9	superficial	superficial	ADJ
dpc-2569	47	10	telangiectasia	telangiectasia	NOUN
dpc-2569	47	11	.	.	PUNCT
dpc-2569	48	1	can	can	AUX
dpc-2569	48	2	med	med	VERB
dpc-2569	48	3	assoc	assoc	PROPN
dpc-2569	48	4	j.	j.	PROPN
dpc-2569	48	5	1983;129(10):1117	1983;129(10):1117	PROPN
dpc-2569	48	6	-	-	PUNCT
dpc-2569	48	7	1118	1118	NUM
dpc-2569	48	8	.	.	PUNCT
dpc-2569	49	1	pmid	pmid	NOUN
dpc-2569	49	2	:	:	PUNCT
dpc-2569	49	3	6627172.pmcid	6627172.pmcid	NUM
dpc-2569	49	4	:	:	PUNCT
dpc-2569	49	5	pmc1875470	pmc1875470	NOUN
dpc-2569	49	6	.	.	PUNCT
dpc-2569	50	1	2	2	X
dpc-2569	50	2	.	.	X
dpc-2569	50	3	uhlin	uhlin	PROPN
dpc-2569	50	4	sr	sr	PROPN
dpc-2569	50	5	,	,	PUNCT
dpc-2569	50	6	mccarty	mccarty	PROPN
dpc-2569	50	7	ks	ks	PROPN
dpc-2569	50	8	jr	jr	PROPN
dpc-2569	50	9	.	.	PROPN
dpc-2569	50	10	unilateral	unilateral	ADJ
dpc-2569	50	11	nevoid	nevoid	PROPN
dpc-2569	50	12	telangiectatic	telangiectatic	ADJ
dpc-2569	50	13	syndrome	syndrome	NOUN
dpc-2569	50	14	.	.	PUNCT
dpc-2569	51	1	the	the	DET
dpc-2569	51	2	role	role	NOUN
dpc-2569	51	3	of	of	ADP
dpc-2569	51	4	estrogen	estrogen	NOUN
dpc-2569	51	5	and	and	CCONJ
dpc-2569	51	6	progesterone	progesterone	NOUN
dpc-2569	51	7	receptors	receptor	NOUN
dpc-2569	51	8	.	.	PUNCT
dpc-2569	52	1	arch	arch	ADJ
dpc-2569	52	2	dermatol	dermatol	NOUN
dpc-2569	52	3	.	.	PUNCT
dpc-2569	53	1	1983;119(3):226	1983;119(3):226	NUM
dpc-2569	53	2	-	-	SYM
dpc-2569	53	3	228	228	NUM
dpc-2569	53	4	.	.	PUNCT
dpc-2569	54	1	doi	doi	NOUN
dpc-2569	54	2	:	:	PUNCT
dpc-2569	54	3	10.1001	10.1001	NUM
dpc-2569	54	4	/	/	SYM
dpc-2569	54	5	archderm.119.3.226	archderm.119.3.226	NOUN
dpc-2569	54	6	.	.	PUNCT
dpc-2569	55	1	pmid	pmid	NOUN
dpc-2569	55	2	:	:	PUNCT
dpc-2569	55	3	6824361	6824361	NUM
dpc-2569	55	4	.	.	PUNCT
dpc-2569	56	1	3	3	X
dpc-2569	56	2	.	.	X
dpc-2569	56	3	jee	jee	PROPN
dpc-2569	56	4	h	h	PROPN
dpc-2569	56	5	,	,	PUNCT
dpc-2569	56	6	kim	kim	PROPN
dpc-2569	56	7	tg	tg	PROPN
dpc-2569	56	8	,	,	PUNCT
dpc-2569	56	9	kim	kim	PROPN
dpc-2569	56	10	ds	ds	PROPN
dpc-2569	56	11	,	,	PUNCT
dpc-2569	56	12	kim	kim	PROPN
dpc-2569	56	13	dy	dy	PROPN
dpc-2569	56	14	,	,	PUNCT
dpc-2569	56	15	lee	lee	PROPN
dpc-2569	56	16	mg	mg	PROPN
dpc-2569	56	17	.	.	PUNCT
dpc-2569	56	18	acquired	acquire	VERB
dpc-2569	56	19	bilateral	bilateral	ADJ
dpc-2569	56	20	nevoid	nevoid	NOUN
dpc-2569	56	21	telangiectasia	telangiectasia	NOUN
dpc-2569	56	22	:	:	PUNCT
dpc-2569	56	23	report	report	NOUN
dpc-2569	56	24	of	of	ADP
dpc-2569	56	25	9	9	NUM
dpc-2569	56	26	cases	case	NOUN
dpc-2569	56	27	.	.	PUNCT
dpc-2569	57	1	eur	eur	PROPN
dpc-2569	57	2	j	j	PROPN
dpc-2569	57	3	dermatology	dermatology	NOUN
dpc-2569	57	4	.	.	PUNCT
dpc-2569	58	1	2013;23(5):736	2013;23(5):736	NUM
dpc-2569	58	2	-	-	SYM
dpc-2569	58	3	737	737	NUM
dpc-2569	58	4	.	.	PUNCT
dpc-2569	59	1	doi	doi	NOUN
dpc-2569	59	2	:	:	PUNCT
dpc-2569	59	3	10.1684	10.1684	NUM
dpc-2569	59	4	/	/	SYM
dpc-2569	59	5	ejd.2013.2141	ejd.2013.2141	PROPN
dpc-2569	59	6	.	.	PUNCT
dpc-2569	60	1	pmid	pmid	NOUN
dpc-2569	60	2	:	:	PUNCT
dpc-2569	60	3	24211825	24211825	NUM
dpc-2569	60	4	.	.	PUNCT
dpc-2569	61	1	4	4	X
dpc-2569	61	2	.	.	X
dpc-2569	61	3	kim	kim	PROPN
dpc-2569	61	4	ej	ej	PROPN
dpc-2569	61	5	,	,	PUNCT
dpc-2569	61	6	park	park	PROPN
dpc-2569	61	7	hs	hs	PROPN
dpc-2569	61	8	,	,	PUNCT
dpc-2569	61	9	yoon	yoon	PROPN
dpc-2569	61	10	hs	hs	PROPN
dpc-2569	61	11	,	,	PUNCT
dpc-2569	61	12	kim	kim	PROPN
dpc-2569	61	13	kh	kh	PROPN
dpc-2569	61	14	,	,	PUNCT
dpc-2569	61	15	cho	cho	PROPN
dpc-2569	61	16	s.	s.	PROPN
dpc-2569	61	17	demographic	demographic	ADJ
dpc-2569	61	18	and	and	CCONJ
dpc-2569	61	19	clinical	clinical	ADJ
dpc-2569	61	20	differences	difference	NOUN
dpc-2569	61	21	between	between	ADP
dpc-2569	61	22	unilateral	unilateral	ADJ
dpc-2569	61	23	and	and	CCONJ
dpc-2569	61	24	bilateral	bilateral	ADJ
dpc-2569	61	25	forms	form	NOUN
dpc-2569	61	26	of	of	ADP
dpc-2569	61	27	naevoid	naevoid	PROPN
dpc-2569	61	28	telangiectasia	telangiectasia	NOUN
dpc-2569	61	29	:	:	PUNCT
dpc-2569	61	30	a	a	DET
dpc-2569	61	31	retrospective	retrospective	ADJ
dpc-2569	61	32	study	study	NOUN
dpc-2569	61	33	with	with	ADP
dpc-2569	61	34	review	review	NOUN
dpc-2569	61	35	of	of	ADP
dpc-2569	61	36	the	the	DET
dpc-2569	61	37	literature	literature	NOUN
dpc-2569	61	38	.	.	PUNCT
dpc-2569	62	1	br	br	PROPN
dpc-2569	62	2	j	j	PROPN
dpc-2569	62	3	dermatol	dermatol	NOUN
dpc-2569	62	4	.	.	PUNCT
dpc-2569	63	1	2015;172(6):1651	2015;172(6):1651	NUM
dpc-2569	63	2	-	-	SYM
dpc-2569	63	3	1653	1653	NUM
dpc-2569	63	4	.	.	PUNCT
dpc-2569	64	1	doi	doi	NOUN
dpc-2569	64	2	:	:	PUNCT
dpc-2569	64	3	10.1111	10.1111	NUM
dpc-2569	64	4	/	/	SYM
dpc-2569	64	5	bjd.13615	bjd.13615	NUM
dpc-2569	64	6	.	.	PUNCT
dpc-2569	65	1	pmid	pmid	NOUN
dpc-2569	65	2	:	:	PUNCT
dpc-2569	65	3	25495722	25495722	NUM
dpc-2569	65	4	.	.	PUNCT
dpc-2569	66	1	5	5	NUM
dpc-2569	66	2	.	.	X
dpc-2569	66	3	sánchez	sánchez	PROPN
dpc-2569	66	4	conejo	conejo	PROPN
dpc-2569	66	5	-	-	PROPN
dpc-2569	66	6	mir	mir	PROPN
dpc-2569	66	7	j	j	PROPN
dpc-2569	66	8	,	,	PUNCT
dpc-2569	66	9	ortega	ortega	PROPN
dpc-2569	66	10	resina	resina	PROPN
dpc-2569	66	11	m	m	PROPN
dpc-2569	66	12	cmf	cmf	PROPN
dpc-2569	66	13	.	.	PROPN
dpc-2569	66	14	unilateral	unilateral	ADJ
dpc-2569	66	15	nevoid	nevoid	PROPN
dpc-2569	66	16	telangiectasia	telangiectasia	PROPN
dpc-2569	66	17	syndrome	syndrome	PROPN
dpc-2569	66	18	.	.	PUNCT
dpc-2569	67	1	study	study	NOUN
dpc-2569	67	2	of	of	ADP
dpc-2569	67	3	cutaneous	cutaneous	ADJ
dpc-2569	67	4	estrogen	estrogen	NOUN
dpc-2569	67	5	receptors	receptor	NOUN
dpc-2569	67	6	.	.	PUNCT
dpc-2569	68	1	med	med	ADJ
dpc-2569	68	2	cutan	cutan	PROPN
dpc-2569	68	3	ibero	ibero	VERB
dpc-2569	68	4	lat	lat	PROPN
dpc-2569	68	5	am	be	AUX
dpc-2569	68	6	.	.	PUNCT
dpc-2569	69	1	1984;12(6):469	1984;12(6):469	NUM
dpc-2569	69	2	-	-	SYM
dpc-2569	69	3	475	475	NUM
dpc-2569	69	4	.	.	PUNCT
dpc-2569	70	1	pmid	pmid	NOUN
dpc-2569	70	2	:	:	PUNCT
dpc-2569	70	3	6397668	6397668	NUM
dpc-2569	70	4	.	.	PUNCT
dpc-2569	71	1	6	6	NUM
dpc-2569	71	2	.	.	X
dpc-2569	71	3	rodríguez	rodríguez	NOUN
dpc-2569	71	4	-	-	PUNCT
dpc-2569	71	5	martín	martín	NOUN
dpc-2569	71	6	m	m	PROPN
dpc-2569	71	7	,	,	PUNCT
dpc-2569	71	8	sáez	sáez	PROPN
dpc-2569	71	9	m	m	PROPN
dpc-2569	71	10	,	,	PUNCT
dpc-2569	71	11	carnerero	carnerero	PROPN
dpc-2569	71	12	a	a	PRON
dpc-2569	71	13	,	,	PUNCT
dpc-2569	71	14	et	et	PROPN
dpc-2569	71	15	al	al	PROPN
dpc-2569	71	16	.	.	PROPN
dpc-2569	71	17	unilateral	unilateral	ADJ
dpc-2569	71	18	naevoid	naevoid	PROPN
dpc-2569	71	19	telangiectasia	telangiectasia	PROPN
dpc-2569	71	20	in	in	ADP
dpc-2569	71	21	a	a	DET
dpc-2569	71	22	young	young	ADJ
dpc-2569	71	23	man	man	NOUN
dpc-2569	71	24	after	after	ADP
dpc-2569	71	25	chemotherapy	chemotherapy	NOUN
dpc-2569	71	26	:	:	PUNCT
dpc-2569	71	27	a	a	DET
dpc-2569	71	28	simple	simple	ADJ
dpc-2569	71	29	coincidence	coincidence	NOUN
dpc-2569	71	30	or	or	CCONJ
dpc-2569	71	31	a	a	DET
dpc-2569	71	32	new	new	ADJ
dpc-2569	71	33	clinical	clinical	ADJ
dpc-2569	71	34	association	association	NOUN
dpc-2569	71	35	?	?	PUNCT
dpc-2569	72	1	j	j	PROPN
dpc-2569	72	2	eur	eur	PROPN
dpc-2569	72	3	acad	acad	PROPN
dpc-2569	72	4	dermatology	dermatology	NOUN
dpc-2569	72	5	venereol	venereol	NOUN
dpc-2569	72	6	.	.	PUNCT
dpc-2569	73	1	2006;20(8):1001	2006;20(8):1001	NUM
dpc-2569	73	2	-	-	PUNCT
dpc-2569	73	3	1002	1002	NUM
dpc-2569	73	4	.	.	PUNCT
dpc-2569	74	1	doi	doi	NOUN
dpc-2569	74	2	:	:	PUNCT
dpc-2569	74	3	10.1111	10.1111	NUM
dpc-2569	74	4	/	/	SYM
dpc-2569	74	5	j.1468	j.1468	NOUN
dpc-2569	74	6	-	-	PUNCT
dpc-2569	74	7	3083.2006.01593.x	3083.2006.01593.x	NOUN
dpc-2569	74	8	.	.	PUNCT
dpc-2569	75	1	pmid	pmid	NOUN
dpc-2569	75	2	:	:	PUNCT
dpc-2569	75	3	16922953	16922953	NUM
dpc-2569	75	4	.	.	PUNCT
dpc-2569	76	1	figure	figure	NOUN
dpc-2569	76	2	1	1	NUM
dpc-2569	76	3	.	.	PUNCT
dpc-2569	76	4	clinical	clinical	ADJ
dpc-2569	76	5	image	image	NOUN
dpc-2569	76	6	of	of	ADP
dpc-2569	76	7	bilateral	bilateral	ADJ
dpc-2569	76	8	nevoid	nevoid	NOUN
dpc-2569	76	9	telangiectasia	telangiectasia	NOUN
dpc-2569	76	10	.	.	PUNCT
dpc-2569	77	1	symmetric	symmetric	PROPN
dpc-2569	77	2	purpuric	purpuric	PROPN
dpc-2569	77	3	linear	linear	ADJ
dpc-2569	77	4	macules	macule	NOUN
dpc-2569	77	5	on	on	ADP
dpc-2569	77	6	the	the	DET
dpc-2569	77	7	arms	arm	NOUN
dpc-2569	77	8	and	and	CCONJ
dpc-2569	77	9	chest	chest	NOUN
dpc-2569	77	10	following	follow	VERB
dpc-2569	77	11	the	the	DET
dpc-2569	77	12	t1	t1	PROPN
dpc-2569	77	13	dermatome	dermatome	NOUN
dpc-2569	77	14	.	.	PUNCT
dpc-2569	78	1	figure	figure	NOUN
dpc-2569	78	2	2	2	NUM
dpc-2569	78	3	.	.	PUNCT
dpc-2569	78	4	clinical	clinical	ADJ
dpc-2569	78	5	image	image	NOUN
dpc-2569	78	6	of	of	ADP
dpc-2569	78	7	bilateral	bilateral	ADJ
dpc-2569	78	8	nevoid	nevoid	NOUN
dpc-2569	78	9	telangiectasia	telangiectasia	NOUN
dpc-2569	78	10	.	.	PUNCT
dpc-2569	79	1	linear	linear	PROPN
dpc-2569	79	2	purpuric	purpuric	ADJ
dpc-2569	79	3	–	–	PUNCT
dpc-2569	79	4	brownish	brownish	ADJ
dpc-2569	79	5	macules	macule	NOUN
dpc-2569	79	6	following	follow	VERB
dpc-2569	79	7	the	the	DET
dpc-2569	79	8	t1	t1	NOUN
dpc-2569	79	9	dermatome	dermatome	NOUN
dpc-2569	79	10	.	.	PUNCT